Main information

  • Trade name:
  • Valve, demand
  • Class:
  • Class IIb
  • Medicine domain:
  • Humans
  • Medicine type:
  • Medical device



  • Available in:
  • Valve, demand
  • Language:
  • English

Other information


  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 220973
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:


APL Group Pty Ltd - Valve, demand

ARTG entry for

Medical Device Included Class IIb


APL Group Pty Ltd

Postal Address

PO Box 1300,UPWEY, VIC, 3158


ARTG Start Date


Product category

Medical Device Class IIb



Approval area

Medical Devices


- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,

Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations

2002 for relevant information.

- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal

offence; and civil penalties may apply.




Ambulanc Shenzhen Tech Co Ltd

East 3/F Block A Nan Yuan Ind Park Xin Yuan

Road Nanshan District

Shenzhen, , 518052



1. Valve, demand

Product Type

Single Device Product

Effective date



17169 Valve, demand

Intended purpose

The Demand Valve Resuscitator (DVR) is a device used to maintain artificial ventilation during respiratory

arrest or to provide oxygen during periods of respiratory distress.

The handheld resuscitator is lightweight, portable and can be operated on either compressed gas or

medical oxygen from either a cylinder or piped-in system. The device comes with a reusable mask.

Specific Conditions

No Specific Conditions included on Record

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at

Public Summary

Page 1 of

Produced at 10.11.2017 at 02:34:39 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information


Danish Pharmacovigilance Update 19 December 2013

Danish Pharmacovigilance Update 19 December 2013

In this issue of Danish Pharmacovigilance Update: Patients with mechanical heart valves should not be treated with the new oral anticoagulants Pradaxa®, Xarelto® and Eliquis®.

Danish Medicines Agency

There are no news related to this product.